Kevin Hendrawan

QIMR Berghofer Medical Research Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade”.

Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2022-006602

N/A

0DataRank · unranked

13 citations

Pei-Yi Yap, Blake Ferguson, Zara C. Bruce, Motoko Koyama, Herlina Y. Handoko +20 more